Apex Labs Ltd.
PrivateLast Round
Series A
Feb 9, 2022
Est. Valuation
$16M
Total Funding Raised
$4M
Company Overview
Apex Labs Ltd. is a pharmaceutical company that develops and commercializes clinically evaluated psilocybin-derived treatments for depression, anxiety, and PTSD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apex Labs Ltd. Comparables
Compare Apex Labs Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reunion Neuroscience Inc. | 81% | |
| Lykos Therapeutics | 77% | |
| Helus Pharma | 76% | |
Apex Labs Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 9, 2022 |
Apex Labs Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iter Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2022
$4M round led by Iter Investments.
Apex Labs Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apex Labs Ltd.'s valuation, stock price, and market status.